These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17392172)
21. The Epitope of PMab-210 Is Located in Platelet Aggregation-Stimulating Domain-3 of Pig Podoplanin. Kaneko MK; Sayama Y; Sano M; Kato Y Monoclon Antib Immunodiagn Immunother; 2019 Dec; 38(6):271-276. PubMed ID: 31663836 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions. Wenzel J; Zeisig R; Fichtner I Clin Exp Metastasis; 2010; 27(1):25-34. PubMed ID: 19916050 [TBL] [Abstract][Full Text] [Related]
23. Role of Platelet C-Type Lectin-Like Receptor 2 in Promoting Lung Metastasis in Osteosarcoma. Ichikawa J; Ando T; Kawasaki T; Sasaki T; Shirai T; Tsukiji N; Kimura Y; Aoki K; Hayakawa K; Suzuki-Inoue K; Saitoh M; Haro H J Bone Miner Res; 2020 Sep; 35(9):1738-1750. PubMed ID: 32479683 [TBL] [Abstract][Full Text] [Related]
24. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis. Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756 [TBL] [Abstract][Full Text] [Related]
25. Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation. Miyata K; Takemoto A; Okumura S; Nishio M; Fujita N Sci Rep; 2017 Jun; 7(1):4059. PubMed ID: 28642617 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Amirkhosravi A; Mousa SA; Amaya M; Blaydes S; Desai H; Meyer T; Francis JL Thromb Haemost; 2003 Sep; 90(3):549-54. PubMed ID: 12958625 [TBL] [Abstract][Full Text] [Related]
27. Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors. Kato Y; Sasagawa I; Kaneko M; Osawa M; Fujita N; Tsuruo T Oncogene; 2004 Nov; 23(52):8552-6. PubMed ID: 15361850 [TBL] [Abstract][Full Text] [Related]
28. Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin. Oki H; Ogasawara S; Kaneko MK; Takagi M; Yamauchi M; Kato Y Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):44-50. PubMed ID: 25723283 [TBL] [Abstract][Full Text] [Related]
29. Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin. Oki H; Kaneko MK; Ogasawara S; Tsujimoto Y; Liu X; Sugawara M; Takakubo Y; Takagi M; Kato Y Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):174-80. PubMed ID: 26090595 [TBL] [Abstract][Full Text] [Related]
30. LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin. Kato Y; Ogasawara S; Oki H; Goichberg P; Honma R; Fujii Y; Kaneko MK PLoS One; 2016; 11(3):e0152912. PubMed ID: 27031228 [TBL] [Abstract][Full Text] [Related]
31. Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity. Kaneko MK; Kunita A; Abe S; Tsujimoto Y; Fukayama M; Goto K; Sawa Y; Nishioka Y; Kato Y Cancer Sci; 2012 Nov; 103(11):1913-9. PubMed ID: 22816430 [TBL] [Abstract][Full Text] [Related]
32. Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. Tani N; Higashiyama S; Kawaguchi N; Madarame J; Ota I; Ito Y; Ohoka Y; Shiosaka S; Takada Y; Matsuura N Br J Cancer; 2003 Jan; 88(2):327-33. PubMed ID: 12610521 [TBL] [Abstract][Full Text] [Related]
33. Arsenic May Act as a Pro-Metastatic Carcinogen Through Promoting Tumor Cell-Induced Platelet Aggregation. Kim K; Heo YK; Chun S; Kim CH; Bian Y; Bae ON; Lee MY; Lim KM; Chung JH Toxicol Sci; 2019 Mar; 168(1):18-27. PubMed ID: 30428081 [TBL] [Abstract][Full Text] [Related]
35. [Stable expression of recombinant human podoplanin in Chinese hamster ovary (CHO) cells]. Qu L; Zhao X; Fu J; Xia L; Dai L; Ruan C; Zhao Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):25-8. PubMed ID: 26728373 [TBL] [Abstract][Full Text] [Related]
36. Extract of Caulis Spatholobi, a novel blocker targeting tumor cell‑induced platelet aggregation, inhibits breast cancer metastasis. Chen X; Li Q; Kan XX; Wang YJ; Li YJ; Yang Q; Xiao HB; Chen Y; Weng XG; Cai WY; Zhu XX Oncol Rep; 2016 Dec; 36(6):3215-3224. PubMed ID: 27779702 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain. Kato Y; Kaneko MK; Kuno A; Uchiyama N; Amano K; Chiba Y; Hasegawa Y; Hirabayashi J; Narimatsu H; Mishima K; Osawa M Biochem Biophys Res Commun; 2006 Nov; 349(4):1301-7. PubMed ID: 16979138 [TBL] [Abstract][Full Text] [Related]
40. A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis. Takemoto A; Okitaka M; Takagi S; Takami M; Sato S; Nishio M; Okumura S; Fujita N Sci Rep; 2017 Feb; 7():42186. PubMed ID: 28176852 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]